Medtronic Names Mark Ploof Senior Vice President of Global Operations and Business Services
September 15 2016 - 8:00AM
Dublin - September 15, 2016 -
Medtronic (NYSE: MDT) today announced the appointment of Mark Ploof
as Senior Vice President, Global Operations and Business Services
effective October 31, 2016. He will serve on the
company's Executive Committee and be responsible for leading
Medtronic's Global Operations, Information Technology, Facilities
& Real Estate and Medtronic Business Services functions, which
include the company's ongoing Covidien acquisition integration
efforts.
Ploof succeeds Gary Ellis who previously announced
plans to retire from the company later this fiscal year after a
27-year Medtronic career. As part of a planned succession, Ellis
will remain on the Medtronic Executive Committee and work with
Ploof to ensure a smooth transition.
"Mark brings a diverse range of experiences to the
Medtronic leadership team as well as a relentless focus on creating
operational excellence, value creation and business growth," said
Omar Ishrak, Medtronic Chairman and CEO. "It is an exciting and
transformational time for Medtronic, and I am confident in Mark's
ability to help us deliver against our strategic business
priorities. From his broad knowledge of operations to his
expertise in assessing and identifying opportunities to operate at
scale and generate margin expansion, Mark's vast experiences in a
multitude of industries will bring fresh thinking and leadership to
our organization."
"I'm excited for this opportunity with Medtronic
and to play such a vital role in helping the company achieve its
Mission around the world," said Ploof. "I am particularly
pleased to join the men and women of Medtronic in these functional
areas who are driving world class business performance and
efficiencies in their work, and I know that we will play an
instrumental part in helping Medtronic realize its operational and
financial goals in the coming years."
Ploof worked with Cerberus Capital Management
portfolio companies to drive margin expansion, efficiency and value
creation efforts in a variety of operations, industries and
roles. He brings a track record of assessing, diagnosing and
remediating opportunities to capture value and institute new
operational and service delivery models to operate efficiently at
scale. His business development background at GE and Cerberus
companies included creating and executing company integration plans
and programs, including facility and supply chain consolidations,
shared services and centers of excellence creation and
organizational development and alignment efforts.
Ploof joins Medtronic from YP, LLC where he most
recently served as the Chief Customer Experience Officer. As a
member of YP's Operating Leadership Team, Ploof oversaw centralized
and field service management, quality and operational enablement,
and business intelligence. He also served as the company's Chief
Restructuring Officer, focused on YP's spin-off from
AT&T. Under his leadership, YP established and drove
significant shareholder returns and significantly improved customer
engagement and satisfaction scores.
Ploof has also held senior leadership roles in
finance, supply chain, business development and sourcing in
Cerberus portfolio companies and at General Electric, where he
established a track record of establishing large scale operating
models that generated meaningful efficiencies and value
creation. Ploof holds a bachelor of business administration
degree in Management from Pace University.
About Medtronic
Medtronic plc (www.medtronic.com), headquartered
in Dublin, Ireland, is among the world's largest medical
technology, services and solutions companies - alleviating pain,
restoring health and extending life for millions of people around
the world. Medtronic employs more than 88,000 people worldwide,
serving physicians, hospitals and patients in approximately 160
countries. The company is focused on collaborating with
stakeholders around the world to take healthcare Further,
Together.
Any forward-looking statements
are subject to risks and uncertainties such as those described in
Medtronic's periodic reports on file with the Securities and
Exchange Commission. Actual results may differ materially from
anticipated results.
-end-
Contacts:
Fernando Vivanco
Public Relations
+1-763-505-3780
Ryan Weispfenning
Investor Relations
+1-763-505-4626
This
announcement is distributed by Nasdaq Corporate Solutions on behalf
of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely
responsible for the content, accuracy and originality of the
information contained therein.
Source: Medtronic plc via Globenewswire
Medtronic (NYSE:MDT)
Historical Stock Chart
From Aug 2024 to Sep 2024
Medtronic (NYSE:MDT)
Historical Stock Chart
From Sep 2023 to Sep 2024